nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylpropanolamine—ADRB1—Endothelin Pathways—ADCY10—nephrolithiasis	0.0545	0.0545	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Endothelin Pathways—ADCY10—nephrolithiasis	0.0441	0.0441	CbGpPWpGaD
Phenylpropanolamine—DRD1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0252	0.0252	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0226	0.0226	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0221	0.0221	CbGpPWpGaD
Phenylpropanolamine—DRD1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0211	0.0211	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.019	0.019	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0188	0.0188	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0186	0.0186	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0183	0.0183	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0175	0.0175	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.017	0.017	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0167	0.0167	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0155	0.0155	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0154	0.0154	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0143	0.0143	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0139	0.0139	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0136	0.0136	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—NRF2 pathway—SLC2A9—nephrolithiasis	0.0126	0.0126	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0123	0.0123	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0113	0.0113	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0113	0.0113	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0112	0.0112	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—NRF2 pathway—SLC2A9—nephrolithiasis	0.0112	0.0112	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0109	0.0109	CbGpPWpGaD
Phenylpropanolamine—MAOA—Biological oxidations—SLC26A1—nephrolithiasis	0.0105	0.0105	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00999	0.00999	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00999	0.00999	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCRs, Other—CHRM3—nephrolithiasis	0.00983	0.00983	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Regulation of insulin secretion—CHRM3—nephrolithiasis	0.00863	0.00863	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00855	0.00855	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00855	0.00855	CbGpPWpGaD
Phenylpropanolamine—DRD1—G alpha (s) signalling events—PTH—nephrolithiasis	0.00798	0.00798	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00795	0.00795	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00795	0.00795	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00757	0.00757	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00757	0.00757	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00724	0.00724	CbGpPWpGaD
Phenylpropanolamine—ADRB1—G alpha (s) signalling events—PTH—nephrolithiasis	0.00717	0.00717	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00708	0.00708	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00704	0.00704	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00704	0.00704	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00703	0.00703	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00703	0.00703	CbGpPWpGaD
Phenylpropanolamine—ADRB2—G alpha (s) signalling events—PTH—nephrolithiasis	0.00702	0.00702	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Integration of energy metabolism—CHRM3—nephrolithiasis	0.00679	0.00679	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00677	0.00677	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.00664	0.00664	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00662	0.00662	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00632	0.00632	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00627	0.00627	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00627	0.00627	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00623	0.00623	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00623	0.00623	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00573	0.00573	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00573	0.00573	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00565	0.00565	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00555	0.00555	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00548	0.00548	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00514	0.00514	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00508	0.00508	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00508	0.00508	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00485	0.00485	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00457	0.00457	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00436	0.00436	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00434	0.00434	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00434	0.00434	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00427	0.00427	CbGpPWpGaD
Phenylpropanolamine—DRD1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00416	0.00416	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00409	0.00409	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00404	0.00404	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00404	0.00404	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.00389	0.00389	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00385	0.00385	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00385	0.00385	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00374	0.00374	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00366	0.00366	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00366	0.00366	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.0036	0.0036	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.0036	0.0036	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00358	0.00358	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00358	0.00358	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00353	0.00353	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—RGS14—nephrolithiasis	0.00333	0.00333	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00329	0.00329	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00328	0.00328	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00322	0.00322	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00319	0.00319	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00319	0.00319	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00317	0.00317	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00303	0.00303	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—RGS14—nephrolithiasis	0.00299	0.00299	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—RGS14—nephrolithiasis	0.00293	0.00293	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—PTH—nephrolithiasis	0.0029	0.0029	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00288	0.00288	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00285	0.00285	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00281	0.00281	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00279	0.00279	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00267	0.00267	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—SLC7A9—nephrolithiasis	0.00265	0.00265	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—DGKH—nephrolithiasis	0.00265	0.00265	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—PTH—nephrolithiasis	0.0026	0.0026	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00255	0.00255	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—PTH—nephrolithiasis	0.00255	0.00255	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00248	0.00248	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00248	0.00248	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.00242	0.00242	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—GRHPR—nephrolithiasis	0.00238	0.00238	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—ADCY10—nephrolithiasis	0.00231	0.00231	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.0023	0.0023	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—RGS14—nephrolithiasis	0.00225	0.00225	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—DGKH—nephrolithiasis	0.00225	0.00225	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00223	0.00223	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—DGKH—nephrolithiasis	0.00218	0.00218	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00214	0.00214	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—AGXT—nephrolithiasis	0.00212	0.00212	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.00211	0.00211	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—ADCY10—nephrolithiasis	0.00208	0.00208	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—ADCY10—nephrolithiasis	0.00203	0.00203	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—DGKH—nephrolithiasis	0.00202	0.00202	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—DGKH—nephrolithiasis	0.00198	0.00198	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—RGS14—nephrolithiasis	0.00197	0.00197	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—PTH—nephrolithiasis	0.00196	0.00196	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—APRT—nephrolithiasis	0.0018	0.0018	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—SLC26A1—nephrolithiasis	0.0018	0.0018	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.0018	0.0018	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00179	0.00179	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—RGS14—nephrolithiasis	0.00177	0.00177	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—RGS14—nephrolithiasis	0.00173	0.00173	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.00168	0.00168	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00167	0.00167	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—PTH—nephrolithiasis	0.00164	0.00164	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.00164	0.00164	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00163	0.00163	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00161	0.00161	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—GRHPR—nephrolithiasis	0.00159	0.00159	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00157	0.00157	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—ADCY10—nephrolithiasis	0.00156	0.00156	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—DGKH—nephrolithiasis	0.00152	0.00152	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—PTH—nephrolithiasis	0.00149	0.00149	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—PTH—nephrolithiasis	0.00147	0.00147	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00146	0.00146	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—PTH—nephrolithiasis	0.00144	0.00144	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.00143	0.00143	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CHRM3—nephrolithiasis	0.00143	0.00143	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—AGXT—nephrolithiasis	0.00142	0.00142	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—PTH—nephrolithiasis	0.00134	0.00134	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—RGS14—nephrolithiasis	0.00133	0.00133	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00133	0.00133	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—DGKH—nephrolithiasis	0.00133	0.00133	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—PTH—nephrolithiasis	0.00131	0.00131	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.0013	0.0013	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—AQP1—nephrolithiasis	0.00128	0.00128	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00121	0.00121	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—SLC26A1—nephrolithiasis	0.0012	0.0012	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—APRT—nephrolithiasis	0.0012	0.0012	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—DGKH—nephrolithiasis	0.00119	0.00119	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00119	0.00119	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.00119	0.00119	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.00118	0.00118	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00117	0.00117	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—DGKH—nephrolithiasis	0.00117	0.00117	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—CHRM3—nephrolithiasis	0.00116	0.00116	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—PTH—nephrolithiasis	0.00111	0.00111	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.0011	0.0011	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.00108	0.00108	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—PTH—nephrolithiasis	0.001	0.001	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000966	0.000966	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.000966	0.000966	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CHRM3—nephrolithiasis	0.00096	0.00096	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000898	0.000898	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—DGKH—nephrolithiasis	0.000898	0.000898	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—PTH—nephrolithiasis	0.000878	0.000878	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.000877	0.000877	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CHRM3—nephrolithiasis	0.000863	0.000863	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—AQP1—nephrolithiasis	0.000858	0.000858	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CHRM3—nephrolithiasis	0.000844	0.000844	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—PTH—nephrolithiasis	0.000789	0.000789	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.000782	0.000782	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—CHRM3—nephrolithiasis	0.000776	0.000776	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—PTH—nephrolithiasis	0.000772	0.000772	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000698	0.000698	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	0.000665	0.000665	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—APRT—nephrolithiasis	0.000665	0.000665	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000649	0.000649	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	0.000639	0.000639	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PTH—nephrolithiasis	0.000593	0.000593	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—AQP1—nephrolithiasis	0.000474	0.000474	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—SPP1—nephrolithiasis	0.000441	0.000441	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CHRM3—nephrolithiasis	0.000428	0.000428	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—SPP1—nephrolithiasis	0.000396	0.000396	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—SPP1—nephrolithiasis	0.000388	0.000388	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	0.000321	0.000321	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—SPP1—nephrolithiasis	0.000298	0.000298	CbGpPWpGaD
